[company_age]7.0[/company_age][employees]nan[/employees][funding]series_unknown[/funding][description]Proactive Diagnostics is a company dedicated to revolutionizing healthcare through innovative diagnostic solutions. Their flagship product, Q-SENS, is a revolutionary point-of-care testing platform that empowers individuals to take control of their health. This technology has the potential to transform healthcare by providing real-time insights into a person's health status, allowing for early detection and intervention of various diseases. Proactive Diagnostics is committed to developing rapid, accessible, and precise immunoassay and molecular testing at the Point-of-Need. Their Q-SENS platform enables the simultaneous detection of proteins, nucleic acids, and small molecules, making it applicable to a wide range of health conditions. The company's unique approach involves using sub-10μL finger-prick blood samples and providing results in just 5-10 minutes. This makes their tests ideal for at-home monitoring of chronic inflammation, allowing individuals to track their inflammation levels and identify potential triggers. Proactive Diagnostics is committed to providing affordable and accessible testing solutions that empower individuals to take control of their health.[/description][ps]Q-SENS: A point-of-care testing platform for monitoring chronic inflammation and immune system response.[/ps]